Takahiro Nishino
Research Subjects
Takahiro Nishino has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Atsushi Sawai
IDEA Consultants, Inc, Institute of Environmental Ecology
1 shared publicationChisato Matsumura
Hyogo Prefectual Institute of Environmental Sciences
1 shared publicationDaichi Asakawa
Osaka City Research Center of Environmental Sciences
1 shared publication- Daisuke Sakamoto
Human-Computer Interaction Lab, Hokkaido University, Sapporo, Japan
1 shared publication - Hidetaka Uramoto
Department of Thoracic Surgery, Kanazawa Medical University, Ishikawa, Japan
1 shared publication - Hiroji Nagata
金沢医科大学病院医療技術部診療放射線技師部
1 shared publication
Latest Publications
- 22 August 2025
- Published by Elsevier in Environmental Pollution
- Vol. 384, 127023
Applicability of artificial sweeteners as markers of wastewater contamination in Japanese surface waters
- 22 August 2025
- Published by Elsevier in Environmental Pollution
- Vol. 384, 127023
Applicability of artificial sweeteners as markers of wastewater contamination in Japanese surface waters
- 22 January 2024
- Published by Oxford University Press (OUP) in Modern Rheumatology
- Vol. 34 (5) , 881-891
Trends in treatment for patients with late-onset rheumatoid arthritis in Japan: Data from the NinJa study
Objectives: Our objective was to investigate trends in the treatment of patients with late-onset rheumatoid arthritis (LORA) using data from the National Database of Rheumatic Diseases in Japan (NinJa). Methods: Patients registered in the National Database of Rheumatic Diseases in Japan were classified according to the disease onset: at <65 years (young-onset rheumatoid arthritis); at 65–74 years (early LORA); and at ≥75 years (late LORA). Chronological changes in the treatment and disease activity were compared. Results: A total of 7178, 13,171, 15,295, and 15,943 patients were evaluated in 2010, 2013, 2016, and 2019, respectively. In all groups, the use of methotrexate gradually decreased, whereas that of biological/targeted synthetic disease-modifying antirheumatic drugs (DMARDs) increased; the use of tumor necrosis factor inhibitors decreased, whereas that of non-tumor necrosis factor inhibitors increased. LORA was characterized by more single DMARD use and less methotrexate and biological/targeted synthetic DMARD use. Tumor necrosis factor inhibitors and interleukin-6 inhibitors were used less frequently, whereas abatacept was utilized more frequently in late versus early LORA. Conventional synthetic DMARD (excluding methotrexate) and glucocorticoid use was higher in late versus early LORA. Conclusions: This analysis revealed chronological changes in the treatment of LORA in Japan. Differences between early and late LORA suggest that patients are not a homogeneous population.
- 22 January 2024
- Published by Oxford University Press (OUP) in Modern Rheumatology
- Vol. 34 (5) , 881-891
Trends in treatment for patients with late-onset rheumatoid arthritis in Japan: Data from the NinJa study
Objectives: Our objective was to investigate trends in the treatment of patients with late-onset rheumatoid arthritis (LORA) using data from the National Database of Rheumatic Diseases in Japan (NinJa). Methods: Patients registered in the National Database of Rheumatic Diseases in Japan were classified according to the disease onset: at <65 years (young-onset rheumatoid arthritis); at 65–74 years (early LORA); and at ≥75 years (late LORA). Chronological changes in the treatment and disease activity were compared. Results: A total of 7178, 13,171, 15,295, and 15,943 patients were evaluated in 2010, 2013, 2016, and 2019, respectively. In all groups, the use of methotrexate gradually decreased, whereas that of biological/targeted synthetic disease-modifying antirheumatic drugs (DMARDs) increased; the use of tumor necrosis factor inhibitors decreased, whereas that of non-tumor necrosis factor inhibitors increased. LORA was characterized by more single DMARD use and less methotrexate and biological/targeted synthetic DMARD use. Tumor necrosis factor inhibitors and interleukin-6 inhibitors were used less frequently, whereas abatacept was utilized more frequently in late versus early LORA. Conventional synthetic DMARD (excluding methotrexate) and glucocorticoid use was higher in late versus early LORA. Conclusions: This analysis revealed chronological changes in the treatment of LORA in Japan. Differences between early and late LORA suggest that patients are not a homogeneous population.
- Open Access
- 20 March 2022
- Published by The Japan Primary Care Association in An Official Journal of the Japan Primary Care Association
- Vol. 45 (1) , 31-35
A Case of Decreased Swallowing Function Due to Cardiac Myxoma
症例は77歳,男性.2年前からめまい・嚥下機能低下があり,むせ,血痰も伴い内科で精査が行われ,原因不明の嚥下機能低下による誤嚥性肺炎の入院歴がある.今回動悸・息切れを伴い近医受診した.心臓超音波検査では,左房内腫瘍が心拍動に伴って僧帽弁に嵌頓していた.当院心臓血管外科で緊急左房粘液腫摘出術,Patch Closureが施行された.摘出術後,嚥下機能が回復したことから術後Ortner症候群と診断された.嚥下機能低下,めまいの原因精査として心臓超音波検査が重要と考えられた一例を経験したので報告する.
- 20 March 2022
- Published by The Japan Primary Care Association in An Official Journal of the Japan Primary Care Association
- Vol. 45 (1) , 31-35
Open AccessA Case of Decreased Swallowing Function Due to Cardiac Myxoma
症例は77歳,男性.2年前からめまい・嚥下機能低下があり,むせ,血痰も伴い内科で精査が行われ,原因不明の嚥下機能低下による誤嚥性肺炎の入院歴がある.今回動悸・息切れを伴い近医受診した.心臓超音波検査では,左房内腫瘍が心拍動に伴って僧帽弁に嵌頓していた.当院心臓血管外科で緊急左房粘液腫摘出術,Patch Closureが施行された.摘出術後,嚥下機能が回復したことから術後Ortner症候群と診断された.嚥下機能低下,めまいの原因精査として心臓超音波検査が重要と考えられた一例を経験したので報告する.
- Open Access
- 10 August 2021
- Published by Springer Nature in Research Square
Ecological Risk Assessment of Pharmaceuticals and Personal Care Products in the Water Environment of 15 Cities in Japan
To assess the ecological risk of pharmaceuticals and personal care products (PPCPs) to the water environment of several cities in Japan, major local environmental research institutes, a private company, and an academic institution launched a joint research project in 2019. Under this initiative, local environmental research institutes surveyed the concentrations of 46 types of PPCPs at 59 points distributed across 15 cities in Japan. IDEA Consultants, Inc. calculated the unknown values of predicted no-effect concentration (PNEC) of six chemicals (telmisartan, candesartan, fexofenadine, diphenhydramine, diphenyl sulfone, and ketotifen) through bioassay experiments on aquatic organisms. Among the researched chemicals, the concentrations of clarithromycin, 14-hydroxyclarithromycin, erythromycin, diclofenac, carbamazepine, and telmisartan exceeded the PNEC in at least one sampling point. However, ozone treatment removed most of these chemicals, except for certain phosphate ester flame retardants. The mass balance of chemicals in the Tamagawa River flowing through Tokyo Prefecture was calculated by multiplying the concentration of each chemical with the flow rate at each sampling point in the river. The measured load of most chemicals at each sampling point of the Tamagawa River coincided to a certain extent with the cumulative load accumulated from the tributaries and sewage treatment plants to the uppermost point (Nagata Bridge). However, the measured load of diclofenac was significantly smaller than the estimated values at each sampling point, suggesting that diclofenac photodegrades while flowing down the river.
- 10 August 2021
- Published by Springer Nature in Research Square
Open AccessEcological Risk Assessment of Pharmaceuticals and Personal Care Products in the Water Environment of 15 Cities in Japan
To assess the ecological risk of pharmaceuticals and personal care products (PPCPs) to the water environment of several cities in Japan, major local environmental research institutes, a private company, and an academic institution launched a joint research project in 2019. Under this initiative, local environmental research institutes surveyed the concentrations of 46 types of PPCPs at 59 points distributed across 15 cities in Japan. IDEA Consultants, Inc. calculated the unknown values of predicted no-effect concentration (PNEC) of six chemicals (telmisartan, candesartan, fexofenadine, diphenhydramine, diphenyl sulfone, and ketotifen) through bioassay experiments on aquatic organisms. Among the researched chemicals, the concentrations of clarithromycin, 14-hydroxyclarithromycin, erythromycin, diclofenac, carbamazepine, and telmisartan exceeded the PNEC in at least one sampling point. However, ozone treatment removed most of these chemicals, except for certain phosphate ester flame retardants. The mass balance of chemicals in the Tamagawa River flowing through Tokyo Prefecture was calculated by multiplying the concentration of each chemical with the flow rate at each sampling point in the river. The measured load of most chemicals at each sampling point of the Tamagawa River coincided to a certain extent with the cumulative load accumulated from the tributaries and sewage treatment plants to the uppermost point (Nagata Bridge). However, the measured load of diclofenac was significantly smaller than the estimated values at each sampling point, suggesting that diclofenac photodegrades while flowing down the river.